Scientific advisory
Integrated biology is at the heart of our system
|
|
Dr. Marc CONTI Ph.D., Pharm. D. Clinical biologist at Bicêtre Hospital of the AP-HP Group
Dr. Conti is the co-author of more than 60 international peer-reviewed publications, mainly in the fields of biochemistry, cellular biology, molecular biology, pharmacology, and pharmacy. Dr. Conti brings invaluable experience in the biochemistry of oxidative stress. As a clinical biologist, he oversees hundreds of thousands of tests each year, both for patients and industrial clients. His experience in diagnostics enables BioQuanta to identify unmet needs in the clinical field and contributes greatly to the development of innovative biomarker assays. Dr. Conti is also one of the main founders of the Mitoxis® platform. |
|
|
|
|
|
Pr. Sylvain LORIC Ph.D. Pasteur, Pharm. D. Head of Clinical Biology Department at Mondor Hospital of the AP-HP Group
Dr. Loric is the co-author of nearly 80 international peer-reviewed publications, mainly in the fields of biochemistry, molecular biology, oncology, genetics, and heredity.
Drawing on his advanced cancer research, Professor Loric has helped define the research goals of biomarker development. His expertise has contributed to several projects in BioQuanta’s product pipeline. Based on his extensive knowledge of molecular biology, Professor Loric was part of the design and improvement of our anti-counterfeiting mark bioInsignis®. |
|
|
|
|
|
Pr. Philippe MANIVET Ph.D. Polytechnique, Pharm. D. Clinical biologist at Lariboisière Hospital of the AP-HP Group Expert with ECVAM (European Centre for the Validation of Alternative Methods)
Professor Manivet is the co-author of more than 30 international peer-reviewed publications, mainly in the field of molecular modeling, molecular biology, genetics, pharmacology, and pharmacy science. Professor Manivet is an expert of in silico methodology. He has designed the tools and methods of the MultiDIP® platform. He has coordinated the intensive use of in silico tools in the development of several molecules for our clients and for our diagnostic projects with the aim of achieving a more efficient process from end to end. |
